EMA
approval
· 2025-12-16
EMA Authorised: Cyanokit (hydroxocobalamin) — SERB SA
Summary
The EMA authorised Cyanokit (hydroxocobalamin) in the EU for the treatment of cyanide poisoning. SERB SA is the marketing authorisation holder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Poisoning. MAH: SERB SA. Decision date: 16/12/2025